CI
IMUC

Cowen Inc’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Cowen Inc’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-5,648
Closed – – 325
2016
Q2 		$0 Hold
5,648
– – ﹤0.01% 350
2016
Q1 		$0 Buy
+5,648
New +$63.5K ﹤0.01% 423
2013
Q3 		– Sell
-1,245
Closed -$97K – 370
2013
Q2 		$97K Buy
+1,245
New +$119K 0.01% 246

Other funds holding IMUC

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $15.9B AUM 53.4% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cowen Inc's IMUC Position: Q3 2016 in Review

Cowen Inc sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q3 2016, closing a stake of 5,648 shares.

Cowen Inc first reported a position in IMUC in Q2 2013 and held it in 3 quarters. The position peaked at $97K in Q2 2013. 31 funds tracked by Wall St. Rank hold IMUC as of Q3 2016.

  • Cowen Inc reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q3 2016 after selling out during the quarter.
  • Cowen Inc sold 5,648 ImmunoCellular Therapeutics, Ltd. shares in Q3 2016.
  • Cowen Inc first reported a position in ImmunoCellular Therapeutics, Ltd. in Q2 2013 and held it in 3 quarters.
  • Cowen Inc's ImmunoCellular Therapeutics, Ltd. position peaked at $97K in Q2 2013.
  • 31 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q3 2016.

Based on Cowen Inc's 13F filing for Q3 2016, filed 14 Nov 2016.